Bessemer leads Boltz $110M Series A
Bessemer Venture Partners is leading a $110 million Series A funding round in Boltz, an AI research lab building foundation models for biomolecular modeling and molecular design. Spun out of MIT, Boltz develops open-source and commercial models like BoltzMol-1 and BoltzProt-1 to automate and accelerate drug discovery and chemistry workflows for pharmaceutical companies. Open article →